Results
Sudarshan Pharma FY26 Net Profit Rises 57%
Sudarshan Pharma reported a 57% YoY increase in standalone net profit to ₹21.98 crore for FY26.
Revenue from operations grew 33% YoY to ₹667.50 crore for the full financial year ended March 2026.
The
